These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30039324)

  • 1. An Update on Immunotherapy for Solid Tumors: A Review.
    Pham T; Roth S; Kong J; Guerra G; Narasimhan V; Pereira L; Desai J; Heriot A; Ramsay R
    Ann Surg Oncol; 2018 Oct; 25(11):3404-3412. PubMed ID: 30039324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision Medicine-Enabled Cancer Immunotherapy.
    Lee JK; Priceman SJ
    Cancer Treat Res; 2019; 178():189-205. PubMed ID: 31209846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Talkin' Toxins: From Coley's to Modern Cancer Immunotherapy.
    Carlson RD; Flickinger JC; Snook AE
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32283684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New directions in immunotherapy for malignant solid tumors].
    Okuno K; Sugiura F; Sukegawa Y; Inoue K
    Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of immunotherapy.
    Disis ML
    Semin Oncol; 2014 Oct; 41 Suppl 5():S3-13. PubMed ID: 25438997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy: current status and future directions.
    Ito F; Chang AE
    Surg Oncol Clin N Am; 2013 Oct; 22(4):765-83. PubMed ID: 24012398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer vaccines and immunotherapies: emerging perspectives.
    Henderson RA; Mossman S; Nairn N; Cheever MA
    Vaccine; 2005 Mar; 23(17-18):2359-62. PubMed ID: 15755628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Re-Analysis of Cancer Vaccine Patients with Immune-Related Clinical Response Criteria(irRC)].
    Nishida K; Saito T; Urakawa S; Mori M; Kakimi K; Doki Y; Wada H
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1466-1468. PubMed ID: 30382047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic active immunotherapy: a new approach to cancer treatment.
    Pan J; Jin P; Yan J; Kabelitz D
    Cancer Immunol Immunother; 2008 Aug; 57(8):1105-14. PubMed ID: 18214475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for solid tumors--a review for surgeons.
    Saied A; Pillarisetty VG; Katz SC
    J Surg Res; 2014 Apr; 187(2):525-35. PubMed ID: 24485876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fifteenth International Conference on Progress in Vaccination against Cancer (PIVAC-15), 6-8 October 2015, Tübingen, Germany: looking back on 15 years of progress.
    Shipp C; Pawelec G
    Cancer Immunol Immunother; 2017 Feb; 66(2):273-279. PubMed ID: 27557906
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dendritic cell vaccines loaded with autologous tumor lysates for solid tumors].
    Kamigaki T; Takahara M; Teruya T
    Nihon Rinsho; 2017 Feb; 75(2):288-294. PubMed ID: 30562866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future approaches in immunotherapy.
    Rini B
    Semin Oncol; 2014 Oct; 41 Suppl 5():S30-40. PubMed ID: 25438998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
    Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
    Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy: on the edge between experimental and clinical oncology.
    Fagnoni FF; Robustelli della Cuna G
    J Chemother; 2001 Feb; 13(1):15-23. PubMed ID: 11233795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.
    Kamigaki T; Kaneko T; Naitoh K; Takahara M; Kondo T; Ibe H; Matsuda E; Maekawa R; Goto S
    Anticancer Res; 2013 Jul; 33(7):2971-6. PubMed ID: 23780988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer.
    Ward JP; Gubin MM; Schreiber RD
    Adv Immunol; 2016; 130():25-74. PubMed ID: 26922999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [History of Immuno-therapy -  from Coley Toxins to Check-points of the Immune Reaction].
    Říhová B; Šťastný M
    Klin Onkol; 2015; 28 Suppl 4():4S8-14. PubMed ID: 26647883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.